Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2013 1
2014 1
2016 2
2017 2
2018 2
2019 6
2020 6
2021 6
2022 7
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases.
Krieckaert CL, van Tubergen A, Gehin JE, Hernández-Breijo B, Le Mélédo G, Balsa A, Böhm P, Cucnik S, Elkayam O, Goll GL, Hooijberg F, Jani M, Kiely PD, McCarthy N, Mulleman D, Navarro-Compán V, Payne K, Perry ME, Plasencia-Rodriguez C, Stones SR, Syversen SW, de Vries A, Ward KM, Wolbink G, Isaacs JD. Krieckaert CL, et al. Among authors: hernandez breijo b. Ann Rheum Dis. 2023 Jan;82(1):65-73. doi: 10.1136/annrheumdis-2022-222155. Epub 2022 May 12. Ann Rheum Dis. 2023. PMID: 35551063
Is the autophagy induced by thiopurines beneficial or deleterious?
Guijarro LG, Román ID, Fernández-Moreno MD, Gisbert JP, Hernández-Breijo B. Guijarro LG, et al. Among authors: hernandez breijo b. Curr Drug Metab. 2012 Nov;13(9):1267-76. doi: 10.2174/138920012803341366. Curr Drug Metab. 2012. PMID: 22493985 Review.
Influence of rheumatoid factor on serum drug levels of TNF inhibitors with different structures in rheumatoid arthritis.
Martínez-Feito A, Plasencia-Rodríguez C, Novella-Navarro M, Gehin JE, Hernández-Breijo B, Brenis CM, Villalba-Yllán A, Fernández E, Monjo-Henry I, Pascual-Salcedo D, Nozal P, Balsa A. Martínez-Feito A, et al. Among authors: hernandez breijo b. Clin Exp Rheumatol. 2024 May;42(5):999-1005. doi: 10.55563/clinexprheumatol/ig40gm. Epub 2024 Jan 8. Clin Exp Rheumatol. 2024. PMID: 38197184 Free article.
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider.
Krieckaert C, Hernández-Breijo B, Gehin JE, le Mélédo G, Balsa A, Jani M, Mulleman D, Navarro-Compan V, Wolbink G, Isaac J, van Tubergen A. Krieckaert C, et al. Among authors: hernandez breijo b. RMD Open. 2022 Jun;8(2):e002216. doi: 10.1136/rmdopen-2022-002216. RMD Open. 2022. PMID: 35980738 Free PMC article. Review.
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease Severity.
Guijarro LG, Cano-Martínez D, Toledo-Lobo MV, Ruiz-Llorente L, Chaparro M, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, García-Sánchez V, Marín-Jiménez I, Barreiro-de Acosta M, Vera I, Martín-Arranz MD, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Zoullas S, Monserrat J, Menor-Salvan C, Alvarez-Mon M, Gisbert JP, Ortega MA, Hernández-Breijo B. Guijarro LG, et al. Among authors: hernandez breijo b. Biomedicines. 2022 Mar 21;10(3):727. doi: 10.3390/biomedicines10030727. Biomedicines. 2022. PMID: 35327530 Free PMC article.
Effect of Infliximab in oxidised serum albumin levels during experimental colitis.
Cano-Martínez D, Román ID, T Lobo MV, Pastor O, Moreno-Villena I, Paradela A, Hernández-Breijo B, Fernández-Moreno MD, Monserrat J, Sanmartín-Salinas P, Gisbert JP, Guijarro LG. Cano-Martínez D, et al. Among authors: hernandez breijo b. Biomarkers. 2014 Dec;19(8):693-701. doi: 10.3109/1354750X.2014.982189. Epub 2014 Nov 10. Biomarkers. 2014. PMID: 25382460
Early monitoring of infliximab serum trough levels predicts long-term therapy failure in patients with axial spondyloarthritis.
Martínez-Feito A, Navarro-Compán V, Hernández-Breijo B, Olariaga-Mérida E, Peiteado D, Villalba A, Nuño L, Monjo I, Diego C, Pascual-Salcedo D, Nozal P, Balsa A, Plasencia-Rodríguez C. Martínez-Feito A, et al. Among authors: hernandez breijo b. Scand J Rheumatol. 2022 Mar;51(2):102-109. doi: 10.1080/03009742.2021.1914430. Epub 2021 Jun 29. Scand J Rheumatol. 2022. PMID: 34182885
Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved.
Guijarro LG, Cano-Martínez D, Toledo-Lobo MV, Salinas PS, Chaparro M, Gómez-Lahoz AM, Zoullas S, Rodríguez-Torres R, Román ID, Monasor LS, Ruiz-Llorente L, Del Carmen Boyano-Adánez M, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, García-Sánchez V, Marín-Jiménez I, Acosta MB, Vera I, Martín-Arranz MD, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Alvarez-Mon M, Gisbert JP, Ortega MA, Hernández-Breijo B, On Behalf Of The Predicrohn Study Group From Geteccu. Guijarro LG, et al. Among authors: hernandez breijo b. Biomed Pharmacother. 2021 Dec;144:112239. doi: 10.1016/j.biopha.2021.112239. Epub 2021 Sep 30. Biomed Pharmacother. 2021. PMID: 34601192 Free article.
35 results